Results 111 to 120 of about 31,995 (218)

Impact of Pneumococcal Conjugate Vaccine Immunization on Nasopharyngeal Carriage of <i>Streptococcus pneumoniae</i> in Vaccinated Children Under 5 Years Old in El Salvador. [PDF]

Open Forum Infect Dis
Dueñas ML, Pérez RA, Santamaría RO, Henríquez PE, Montano E, José M, Mendoza EW, Alvarado ÁE, Salguero ER, Barahona GE, Torres JR.   +10 more
europepmc   +1 more source

Safety and immunogenicity of 13-Valent pneumococcal conjugate vaccine in healthy infants in Shanghai during the COVID-19 pandemic: a prospective cohort study. [PDF]

Front Immunol
Xin L, Hong L, Wang S, Qian X, Li Y.
europepmc   +1 more source

Genomic features of pneumococcal strains isolated from paediatric patients with invasive disease during pneumococcal conjugate vaccine introduction in Lima, Peru. [PDF]

Microb Genom
Gonzales BE, Durand D, Mercado EH, Lopez-Briceño M, González L, Grupo Peruano de Investigación En Neumococo Gpin, Ochoa TJ.   +6 more
europepmc   +1 more source

Efficacy, immunogenicity, and safety of pneumococcal conjugate vaccine in children: a systematic review and meta-analysis. [PDF]

Front Pediatr
Dai Q, Dong Y, Wu J, Peng Q.
europepmc   +1 more source

The lights went out.

, 2012
Cavelaars, Chen, Cholesterol Treatment Trialists' Ctt Collaboration, Kromhout, Kunitz, Leon, S. Ebrahim, Uusitalo   +7 more
core   +1 more source

Cost-effectiveness and return on investment of 20-valent pneumococcal conjugate vaccine use among adults in England: analysis from the societal perspective. [PDF]

Cost Eff Resour Alloc
Mendes D, Averin A, Atwood M, Sato R, Vyse A, Campling J, Hariharan D, Weycker D, Mugwagwa T, Vietri J.   +9 more
europepmc   +1 more source

Effectiveness of 10-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia and invasive pneumococcal disease among young children in Mozambique. [PDF]

Vaccine
Sigaúque B, Vilanculos L, Chaúque A, Moiane B, Mucavele H, Massora S, Acácio S, Sacoor C, Quintó L, Matsinhe B, Pimenta F, Whitney CG, Lessa FC, da Glória Carvalho M, Verani JR.   +14 more
europepmc   +1 more source

Chronicling the Journey of Pneumococcal Conjugate Vaccine Introduction in India. [PDF]

Vaccines (Basel)
Kumar P, Ray A, Kumari A, Sultana A, Hora R, Singh K, Mehra R, Kaur A, Koshal SS, Quadri SF, Singh SK, Roy AD.   +11 more
europepmc   +1 more source

Immunogenicity and safety of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults ≥18 years of age in India: A phase 3 single-arm trial. [PDF]

Hum Vaccin Immunother
Giriappa B, Choraria N, Ponce P, Drozd J, Su X, Lei L, Portka M, Pai S, Anderson A, Bickham K, Watson W, McElwee K.   +11 more
europepmc   +1 more source

Association between introduction of 13-valent pneumococcal conjugate vaccine and burden of hospitalized adult pneumococcal disease in Hong Kong - A retrospective database study. [PDF]

Hum Vaccin Immunother
Yu Q, Chui CSL, Yeo SH, Patel D, Lim CTK, Li X, Chan VKY, Yamada E, Sukarom I.   +8 more
europepmc   +1 more source